TLR-3 stimulation improves anti-tumor immunity elicited by dendritic cell exosome-based vaccines in a murine model of melanoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TLR-3 stimulation improves anti-tumor immunity elicited by dendritic cell exosome-based vaccines in a murine model of melanoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-12-03
DOI
10.1038/srep17622
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dendritic Cell-Based Vaccination in Cancer: Therapeutic Implications Emerging from Murine Models
- (2015) Soledad Mac Keon et al. Frontiers in Immunology
- Dendritic-cell exosomes cross-present Toll-like receptor-ligands and activate bystander dendritic cells
- (2014) Andrea Sobo-Vujanovic et al. CELLULAR IMMUNOLOGY
- Lymph node stromal cells acquire peptide–MHCII complexes from dendritic cells and induce antigen-specific CD4+T cell tolerance
- (2014) Juan Dubrot et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Dendritic Cell-Derived Exosomes as Immunotherapies in the Fight against Cancer
- (2014) J. M. Pitt et al. JOURNAL OF IMMUNOLOGY
- Enhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes
- (2014) L. Jeanbart et al. Cancer Immunology Research
- Interferon response factor 3 is crucial to poly-I:C induced NK cell activity and control of B16 melanoma growth
- (2013) Tyler C. Moore et al. CANCER LETTERS
- A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside
- (2013) C. L.-L. Chiang et al. CLINICAL CANCER RESEARCH
- Dendritic Cell-Derived Exosomes Need To Activate Both T and B Cells To Induce Antitumor Immunity
- (2013) T. I. Naslund et al. JOURNAL OF IMMUNOLOGY
- Cancer immunotherapy with exosomes requires B-cell activation
- (2013) Tanja I Näslund et al. OncoImmunology
- Cancer immunotherapy
- (2012) Thomas F. Gajewski Molecular Oncology
- Anticancer function of polyinosinic-polycytidylic acid
- (2011) Yu-sheng Cheng et al. CANCER BIOLOGY & THERAPY
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination
- (2011) C. Nembrini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dendritic Cell-Derived Exosomes for Cancer Immunotherapy: What's Next?
- (2010) S. Viaud et al. CANCER RESEARCH
- Adjuvants for cancer vaccines
- (2010) Thomas W. Dubensky et al. SEMINARS IN IMMUNOLOGY
- TLR-based immune adjuvants
- (2010) Folkert Steinhagen et al. VACCINE
- Antigen-loaded exosomes alone induce Th1-type memory through a B cell-dependent mechanism
- (2009) K. R. Qazi et al. BLOOD
- Immune Therapy for Cancer
- (2008) Michael Dougan et al. Annual Review of Immunology
- Sentinel lymph node as a target of molecular diagnosis of lymphatic micrometastasis and local immunoresponse to malignant cells
- (2008) Hiroya Takeuchi et al. CANCER SCIENCE
- Treatment of Vulvar Intraepithelial Neoplasia with Topical Imiquimod
- (2008) Manon van Seters et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started